Merck Anti Covid Pill
- All
- News
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
2 Covid Pills - But Who Should Get Them? The New Dilemma
The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.
